BNTX logo

BioNTech SE (BNTX) Net income

annual net income:

-$720.09M-$1.73B(-171.50%)
December 31, 2024

Summary

  • As of today (April 17, 2025), BNTX annual net profit is -$720.09 million, with the most recent change of -$1.73 billion (-171.50%) on December 31, 2024.
  • During the last 3 years, BNTX annual net income has fallen by -$12.90 billion (-105.91%).
  • BNTX annual net income is now -105.91% below its all-time high of $12.18 billion, reached on December 31, 2021.

Performance

BNTX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

quarterly net income:

$276.61M+$58.74M(+26.96%)
December 31, 2024

Summary

  • As of today (April 17, 2025), BNTX quarterly net profit is $276.61 million, with the most recent change of +$58.74 million (+26.96%) on December 31, 2024.
  • Over the past year, BNTX quarterly net income has increased by +$58.74 million (+26.96%).
  • BNTX quarterly net income is now -93.34% below its all-time high of $4.15 billion, reached on March 31, 2022.

Performance

BNTX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM net income:

-$717.57M-$216.50M(-43.21%)
December 31, 2024

Summary

  • As of today (April 17, 2025), BNTX TTM net profit is -$717.57 million, with the most recent change of -$216.50 million (-43.21%) on December 31, 2024.
  • Over the past year, BNTX TTM net income has dropped by -$216.50 million (-43.21%).
  • BNTX TTM net income is now -104.81% below its all-time high of $14.92 billion, reached on March 31, 2022.

Performance

BNTX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BNTX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-171.5%+27.0%-43.2%
3 y3 years-105.9%-84.6%-106.3%
5 y5 years-259.1%+212.6%-53.9%

BNTX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-105.9%at low-93.3%+131.8%-104.8%at low
5 y5-year-105.9%at low-93.3%+131.8%-104.8%at low
alltimeall time-105.9%at low-93.3%+131.8%-104.8%at low

BioNTech SE Net income History

DateAnnualQuarterlyTTM
Dec 2024
-$720.09M(-171.5%)
$276.61M(+27.0%)
-$717.57M(+43.2%)
Sep 2024
-
$217.87M(-125.0%)
-$501.07M(-7.9%)
Jun 2024
-
-$869.80M(+154.1%)
-$544.08M(-560.7%)
Mar 2024
-
-$342.26M(-169.4%)
$118.10M(-88.2%)
Dec 2023
$1.01B(-89.9%)
$493.12M(+182.0%)
$999.74M(-64.8%)
Sep 2023
-
$174.86M(-184.2%)
$2.84B(-36.4%)
Jun 2023
-
-$207.62M(-138.5%)
$4.46B(-30.8%)
Mar 2023
-
$539.38M(-76.9%)
$6.45B(-35.9%)
Dec 2022
$9.95B(-18.3%)
$2.33B(+29.6%)
$10.06B(-11.4%)
Sep 2022
-
$1.80B(+1.0%)
$11.35B(-14.9%)
Jun 2022
-
$1.78B(-57.1%)
$13.34B(-10.6%)
Mar 2022
-
$4.15B(+14.6%)
$14.92B(+23.0%)
Dec 2021
$12.18B
$3.62B(-4.4%)
$12.13B(+35.6%)
DateAnnualQuarterlyTTM
Sep 2021
-
$3.79B(+12.7%)
$8.94B(+82.1%)
Jun 2021
-
$3.36B(+147.1%)
$4.91B(+237.7%)
Mar 2021
-
$1.36B(+210.7%)
$1.45B(+3972.1%)
Dec 2020
$17.36M(-108.7%)
$437.46M(-278.1%)
$35.71M(-107.7%)
Sep 2020
-
-$245.57M(+152.5%)
-$466.27M(+83.4%)
Jun 2020
-
-$97.25M(+65.0%)
-$254.17M(+19.2%)
Mar 2020
-
-$58.93M(-8.7%)
-$213.19M(+6.4%)
Dec 2019
-$200.50M(+253.6%)
-$64.52M(+92.8%)
-$200.43M(+45.8%)
Sep 2019
-
-$33.47M(-40.5%)
-$137.45M(+4.7%)
Jun 2019
-
-$56.26M(+21.9%)
-$131.22M(+75.1%)
Mar 2019
-
-$46.17M(+2893.1%)
-$74.96M(+160.4%)
Dec 2018
-$56.70M(-41.5%)
-$1.54M(-94.3%)
-$28.79M(+5.7%)
Sep 2018
-
-$27.25M
-$27.25M
Dec 2017
-$97.00M
-
-

FAQ

  • What is BioNTech SE annual net profit?
  • What is the all time high annual net income for BioNTech SE?
  • What is BioNTech SE annual net income year-on-year change?
  • What is BioNTech SE quarterly net profit?
  • What is the all time high quarterly net income for BioNTech SE?
  • What is BioNTech SE quarterly net income year-on-year change?
  • What is BioNTech SE TTM net profit?
  • What is the all time high TTM net income for BioNTech SE?
  • What is BioNTech SE TTM net income year-on-year change?

What is BioNTech SE annual net profit?

The current annual net income of BNTX is -$720.09M

What is the all time high annual net income for BioNTech SE?

BioNTech SE all-time high annual net profit is $12.18B

What is BioNTech SE annual net income year-on-year change?

Over the past year, BNTX annual net profit has changed by -$1.73B (-171.50%)

What is BioNTech SE quarterly net profit?

The current quarterly net income of BNTX is $276.61M

What is the all time high quarterly net income for BioNTech SE?

BioNTech SE all-time high quarterly net profit is $4.15B

What is BioNTech SE quarterly net income year-on-year change?

Over the past year, BNTX quarterly net profit has changed by +$58.74M (+26.96%)

What is BioNTech SE TTM net profit?

The current TTM net income of BNTX is -$717.57M

What is the all time high TTM net income for BioNTech SE?

BioNTech SE all-time high TTM net profit is $14.92B

What is BioNTech SE TTM net income year-on-year change?

Over the past year, BNTX TTM net profit has changed by -$216.50M (-43.21%)
On this page